Journal Logo

September 1998 - Volume 32 - Issue 3
pp: 337-508

Pharmacokinetics and Pharmacodynamics of Sibrafiban (Ro 48-3657), an Orally Active IIb/IIIa Antagonist, Administered Alone or in Combination with Heparin, Aspirin, and Recombinant Tissue-Type Plasminogen Activator in Beagles

Modi, Nishit B.; Lin, Yvonne S.; Reynolds, Theresa; More

Journal of Cardiovascular Pharmacology. 32(3):397-405, September 1998.


Show: